Methyl 4-chlorothieno[3,2-c]pyridine-2-carboxylate

Catalog No.: 
ACDWHS879
CAS No.: 
1315364-06-7
Molecular Formula: 
C9H6ClNO2S
Molecular Weight: 
227.67
Methyl 4-chlorothieno[3,2-c]pyridine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$268.00InquiryInquiry
100mg97%$390.00InquiryInquiry
250mg97%$549.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-chlorothieno[3,2-c]pyridine-2-carboxylate
IUPAC Namemethyl 4-chlorothieno[3,2-c]pyridine-2-carboxylate
MDL No.0
Molecular FormulaC9H6ClNO2S
Molecular Weight227.67
SMILESO=C(C(S1)=CC2=C1C=CN=C2Cl)OC
InChI KeyGSMBIBQIYVACCI-UHFFFAOYSA-N
Synonymmethyl 4-chlorothieno[3,2-c]pyridine-2-carboxylate;Thieno[3,2-c]pyridine-2-carboxylic acid, 4-chloro-, methyl ester
CAS No.1315364-06-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDWHS879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDWHS879 route product structure diagram
    ACDWHS8791315364-06-7
Inquiry

2. ACDWHS879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPODC374 route compound structure diagram
    ACPODC3741360965-52-1In Stock
  2. Then
  3. ACDWHS879 route product structure diagram
    ACDWHS8791315364-06-7
Inquiry

3. ACDWHS879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRUWL284 route compound structure diagram
    ACRUWL28428948-61-0In Stock
  4. Then
  5. ACDWHS879 route product structure diagram
    ACDWHS8791315364-06-7
Inquiry

Comments (0)